/CARA.ST
CARA.ST Stock - Carasent AB (publ)
Healthcare|Medical - Healthcare Information ServicesSTO
$27.15+1.88%
+$0.50 (+1.88%) • Dec 23
68
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.55
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $29.87
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for CARA.ST
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$26.88 – $27.42
TARGET (TP)$31.22
STOP LOSS$24.98
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-0.99
52W High$31.25
52W Low$19.60
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $275.26M | $243.98M | $195.26M | $137.13M | $70.58M |
| Gross Profit | $232.71M | $197.77M | $161.42M | $112.90M | $56.79M |
| Gross Margin | 84.5% | 81.1% | 82.7% | 82.3% | 80.5% |
| Operating Income | $-54,502,000 | $-77,522,000 | $-1,361,000 | $9.65M | $3.43M |
| Net Income | $-42,259,000 | $-46,445,000 | $31.17M | $-148,000 | $-38,131,000 |
| Net Margin | -15.4% | -19.0% | 16.0% | -0.1% | -54.0% |
| EPS | $-0.58 | $-0.60 | $0.39 | $-0.00 | $-0.85 |
Company Overview
Carasent AB (publ) provides cloud based electronic health record (EHR) systems solutions and platform services for healthcare sector in Nordics and Germany. The company offers Webdoc, Webdoc X, Metodika, Ad Curis, Ad Opus, and Data-AL solutions. It also provides Medrave, Vårdrummet, Ad Voca, and HPI Plustoo services, as well as an ecosystem of platform services, including solutions for patient communication and business intelligence. The company was founded in 1997 and is headquartered in Gothenburg, Sweden.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
CARA.STBeat Rate
67%
Last 15 quarters
Avg Surprise
+132.2%
EPS vs Estimate
Beats / Misses
10/5
Last 12 quarters
Latest EPS
$0.20
Q4 2025
EPS Surprise History
Q2 23
+125.2%
$0.01vs$0.00
Q3 23
-255.0%
$-0.06vs$-0.02
Q4 23
-83.3%
$-0.06vs$-0.03
Q1 24
+890.1%
$0.16vs$0.02
Q2 24
-1600.0%
$-0.15vs$0.01
Q3 24
+900.0%
$0.16vs$0.02
Q4 24
-14.3%
$0.06vs$0.07
Q4 25
+233.3%
$0.20vs$0.06
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Oct 16, 2025 | $0.06 | $0.20 | +233.3% | ✓ BEAT |
Q3 2025 | Jul 14, 2025 | — | — | — | — |
Q2 2025 | Apr 22, 2025 | — | — | — | — |
Q1 2025 | Feb 13, 2025 | $0.05 | — | — | — |
Q4 2024 | Oct 24, 2024 | $0.07 | $0.06 | -14.3% | ✗ MISS |
Q3 2024 | Jul 16, 2024 | $0.02 | $0.16 | +900.0% | ✓ BEAT |
Q2 2024 | Apr 24, 2024 | $0.01 | $-0.15 | -1600.0% | ✗ MISS |
Q1 2024 | Feb 15, 2024 | $0.02 | $0.16 | +890.1% | ✓ BEAT |
Q4 2023 | Oct 26, 2023 | $-0.03 | $-0.06 | -83.3% | ✗ MISS |
Q3 2023 | Jul 14, 2023 | $-0.02 | $-0.06 | -255.0% | ✗ MISS |
Q2 2023 | May 4, 2023 | $0.00 | $0.01 | +125.2% | ✓ BEAT |
Q1 2023 | Feb 15, 2023 | $-0.03 | $0.01 | +132.0% | ✓ BEAT |
Q4 2022 | Oct 26, 2022 | $0.08 | $0.18 | +125.0% | ✓ BEAT |
Q3 2022 | Jul 15, 2022 | $0.07 | $0.08 | +14.3% | ✓ BEAT |
Q2 2022 | Apr 28, 2022 | $0.03 | $0.35 | +1050.2% | ✓ BEAT |
Q1 2022 | Feb 10, 2022 | $0.04 | $0.24 | +500.0% | ✓ BEAT |
Q4 2021 | Oct 27, 2021 | $0.10 | $-0.26 | -360.0% | ✗ MISS |
Q3 2021 | Aug 18, 2021 | $0.08 | $0.34 | +325.0% | ✓ BEAT |
Q2 2021 | Apr 28, 2021 | — | $-0.14 | — | — |
Q1 2021 | Feb 16, 2021 | — | $-0.55 | — | — |
Latest News
Loading news...
Frequently Asked Questions about CARA.ST
What is CARA.ST's current stock price?
Carasent AB (publ) (CARA.ST) is currently trading at $27.15 per share. The stock has moved +1.88% today.
What is the analyst price target for CARA.ST?
No analyst price targets are currently available for this stock.
What sector is Carasent AB (publ) in?
Carasent AB (publ) operates in the Healthcare sector, specifically within the Medical - Healthcare Information Services industry. The company is traded on the STO exchange.
What is CARA.ST's market cap?
Carasent AB (publ) has a market capitalization of $1.93 billion, making it a small-cap company.
Does CARA.ST pay dividends?
No, Carasent AB (publ) does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBICO.ST
BICO Group AB (publ)
$19.00
Mkt Cap: $1.3B
BINV.ST
BioInvent International AB (publ)
$29.75
Mkt Cap: $2.0B
DVYSR.ST
Devyser Diagnostics AB (publ)
$113.80
Mkt Cap: $1.9B
EGTX.ST
Egetis Therapeutics AB (publ)
$5.30
Mkt Cap: $1.9B
HUM.ST
Humana AB (publ)
$49.65
Mkt Cap: $2.4B
OSSD.ST
OssDsign AB (publ)
$11.46
Mkt Cap: $1.3B
PAX.ST
Paxman AB (publ)
$54.00
Mkt Cap: $1.3B
SANION.ST
Saniona AB (publ)
$20.60
Mkt Cap: $2.8B
STIL.ST
Stille AB
$208.00
Mkt Cap: $1.9B
VICO.ST
Vicore Pharma Holding AB (publ)
$11.08
Mkt Cap: $2.6B
Explore stocks similar to CARA.ST for comparison